Skip to main content
SpringerLink
Log in

Use of Over-the-Counter Drugs in Migraine

Issues in Self-Medication

  • Current Opinion
  • Published:
CNS Drugs Aims and scope Submit manuscript

Summary

Migraine is a prevalent condition worldwide. It has far-reaching individual and societal economic impact. Almost all migraineurs (95%) take medications for headache relief and the majority use over-the-counter (OTC) medications. OTC drugs are readily accessible, affordable and effective. These medications are commonly used without the advice of a healthcare professional, hence the potential for negative health outcomes due to improper use. To avoid these problems and their potentially harmful consequences (e.g. toxicity, adverse effects), major efforts should be directed towards educating the public about migraine and its treatment, including the appropriate use of OTC medications.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Isler H. Historical background. In: Olesen J, Tfelt-Hansen P, Welch KMA, editors. The headaches. New York: Raven Press Ltd, 1993: 1–8

    Google Scholar 

  2. Headache Classification Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia 1988; 8 Suppl. 7: 1–96

    Google Scholar 

  3. Stewart WF, Lipton RB, Celentano DO, et al. Prevalence of migraine headache in the United States. JAMA 1992; 267: 64–9

    Article  PubMed  CAS  Google Scholar 

  4. Lipton LB, Silberstein SD, Stewart WF. An update on the epidemiology of migraine. Headache 1994; 34: 319–28

    Article  PubMed  CAS  Google Scholar 

  5. Edmeads J, Findlay H, Tugwell P, et al. Impact of migraine headache and tension-type headache on life-style, consulting behaviour, and medication use: a Canadian population survey. Can J Neurol Sci 1993; 20: 131–7

    PubMed  CAS  Google Scholar 

  6. Henry P, Michel P, Brochet B, et al. A nationwide survey of migraine in France: prevalence and clinical features in adults. Cephalalgia 1992; 12: 229–37

    Article  PubMed  CAS  Google Scholar 

  7. Rasmussen BK. Epidemiology of headache. Cephalalgia 1995; 15: 45–68

    PubMed  CAS  Google Scholar 

  8. Gobel H, Petersen-Braun M, Soyka D. Headache in Germany. A nationwide survey of a representative sample on the basis of the headache classification of the International Headache Society. In: Olesen J, editor. Frontiers in headache research. Vol. 4: Headache classification and epidemiology. New York: Raven Press Ltd, 1994: 225–61

    Google Scholar 

  9. Stewart WF, Shechter BA, Rasmussen BK. Migraine prevalence: a review of population-based studies. Neurology 1994; 44 Suppl. 4: S17–23

    PubMed  CAS  Google Scholar 

  10. Lipton RB, Stewart WF. Migraine in the United States: a review of epidemiology and health care use. Neurology 1993; 43 Suppl. 3: S6–10

    PubMed  CAS  Google Scholar 

  11. Lipton RB, Stewart WF. The epidemiology of migraine. Eur Neurol 1994; 34 Suppl. 2: 6–11

    Article  PubMed  Google Scholar 

  12. Edmeads J. The diagnosis and treatment of migraine: a c1inician’s view. Eur Neurol 1994; 34 Suppl. 2: 2–5

    Article  PubMed  Google Scholar 

  13. Lipton RB, Stewart WF. Medical consultation for migraine [abstract]. Neurology 1994; 44 Suppl. 2: A199

    Google Scholar 

  14. Stang PE, Osterhaus JT, Celentano DD. Migraine: patterns of healthcare use. Neurology 1994; 44 Suppl. 4: S47–55

    PubMed  CAS  Google Scholar 

  15. Stewart WF, Lipton RB. Migraine awareness in US women [abstract]. Neurology 1992; 42 Suppl. 3: 262

    Google Scholar 

  16. Lipton RB, Stewart WF, Celentano DD, et al. Undiagnosed migraine headaches: a comparison of symptom-based and reported physician diagnosis. Arch Intern Med 1992; 152: 1273–8

    Article  PubMed  CAS  Google Scholar 

  17. Celentano DD, Stewart WF, Lipton RB, et al. Medication use and disability among migraineurs: a national probability sample survey. Headache 1992; 32: 223–8

    Article  PubMed  CAS  Google Scholar 

  18. Sheftell F. Educating headache patients: the role of The American Council for Headache Education (ACHE). Headache 1994; Suppl. 1: 27–8

    Google Scholar 

  19. Lipton RB, Newman LC, Solomon S. Over-the-counter medication and the treatment of migraine. Headache 1994; 34: 547–8

    Article  PubMed  CAS  Google Scholar 

  20. Solomon S. OTC analgesics in treating common primary headaches: a review of safety and efficacy. Headache 1994; Suppl. I: 13–21

    Google Scholar 

  21. Diener HC. A review of current treatments for migraine. Eur Neurol 1994; 34 Suppl. 2: 18–25

    Article  PubMed  Google Scholar 

  22. Horn J. Pharmacology of over-the-counter analgesics used for the treatment of headache. Headache 1994; Suppl. 1: 6–9

    Google Scholar 

  23. Havanka-Kanniainen H. Treatment of acute migraine attack: ibuprofen and placebo compared. Headache 1989; 29: 507–9

    Article  PubMed  CAS  Google Scholar 

  24. Nestvold K, Kloster R, Partinen M, et al. Treatment of acute migraine attack: naproxen and placebo compared. Cephalalgia 1985; 5: 115–9

    Article  PubMed  CAS  Google Scholar 

  25. Johnson ES, Ratcliffe DM, Wilkinson M. Naproxen sodium in the treatment of migraine. Cephalalgia 1985; 5: 5–10

    Article  PubMed  CAS  Google Scholar 

  26. Kangasniemi P, Kaaja R. Ketoprofen and ergotamine in acute migraine. J Intern Med 1992; 231: 551–4

    Article  PubMed  CAS  Google Scholar 

  27. Pfaffenrath V, Scherzer S. Analgesics and NSAIDs in the treatment of the acute migraine attack. Cephalalgia 1995; Suppl. 15: 14–20

    Google Scholar 

  28. Tfelt-Hansen P, Johnson ES. Nonsteroidal antiinflammatory drugs in the treatment of the acute migraine attack. In: Olesen J, Tfelt-Hansen P, Welch KMA, editors. The headaches. New York: Raven Press Ltd, 1994: 305–11

    Google Scholar 

  29. Johnson ES, Tfelt-Hansen P. Nonsteroidal antiinflammatory drugs. In: Olesen J, Tfelt-Hansen P, Welch KMA, editors. The headaches. New York: Raven Press Ltd, 1994: 391–5

    Google Scholar 

  30. Welch KMA, Ellis DJ, Keenan PA. Successful migraine prophylaxis with naproxen sodium. Neurology 1985; 35: 1304–10

    Article  PubMed  CAS  Google Scholar 

  31. Buring JE, Peto R, Hennekens CH. Low-dose aspirin for migraine prophylaxis. JAMA 1990; 264: 1711–3

    Article  PubMed  CAS  Google Scholar 

  32. Silberstein SD, Lipton RB. Overview of diagnosis and treatment of migraine. Neurology 1994; 44 Suppl. 7: 56–16

    Google Scholar 

  33. Dalessio DJ. Caffeine as an analgesic adjuvant: review of the evidence. Headache 1994; Suppl. 1: 10–2

    Google Scholar 

  34. Silverman K, Evans SM, Strain EC, et al. Withdrawal syndrome after the double-blind cessation of caffeine consumption. N Engl J Med 1992; 327: 1109–14

    Article  PubMed  CAS  Google Scholar 

  35. MacGregor EA, Vohran C, Wilkinson M. Analgesic use: a study of treatments used by patients for migraine prior to attending The City of London Migraine Clinic. Headache 1990; 30: 571–4

    Article  PubMed  CAS  Google Scholar 

  36. Robinson RG. Pain relief for headaches: is self-medication a problem? Can Fam Physician 1993; 39: 867–72

    PubMed  CAS  Google Scholar 

  37. Murphy JJ, Heptinstall S, Mitchell JRA. Randomised double-blind placebo-controlled trial of feverfew in migraine prevention. Lancet 1988; II(8604): 189–92

    Article  Google Scholar 

  38. Schoenen J, Lenaerts M, Bastings E. High-dose riboflavin as a prophylactic treatment of migraine: results of an open pilot study. Cephalalgia 1994; 14: 328–9

    Article  PubMed  CAS  Google Scholar 

  39. Gobel H, Schmidt G, Soyka D. Effect of peppermint oil and eucalyptus oil preparations on neurophysiological and experimental algesimetric headache parameters. Cephalalgia. 1994; 14 (3): 228–34

    Article  PubMed  CAS  Google Scholar 

  40. Peikert A, Wilirnzig C, Kohne-Volland R. Prophylaxis of migraine with oral magnesium: results from a prospective, multi-center, placebo-controlled and double-blind randomized study. Cephalalgia 1996; 16: 257–63

    Article  PubMed  CAS  Google Scholar 

  41. Pfaffenrath V, Wessely D, Meyer C, et al. Magnesium in the prophylaxis of migraine — a double-blind, placebo controlled study. Cephalalgia. In press

  42. Stewart WF, Lipton RB. Migraine headache: epidemiology and health care utilization. Cephalalgia 1993; 13 Suppl. 12: 41–6

    PubMed  Google Scholar 

  43. Salomone III JA, Thomas RW, Althoff JR, et al. An evaluation of the role of the ED in the management of migraine headaches. Am J Emerg Med 1994; 12: 134–7

    Article  PubMed  Google Scholar 

  44. Nichol MB, McCombs JS, Johnson KA. The effects of consultation on over-the-counter medication purchasing decisions. Med Care 1992; 30: 989–1003

    Article  PubMed  CAS  Google Scholar 

  45. Mathew NT. Chronic refractory headache. Neurology 1993; 43 Suppl. 3: S26–33

    PubMed  CAS  Google Scholar 

  46. Welch KMA. Drug therapy of migraine. N Engl J Med 1993; 329 (20): 1476–83

    Article  PubMed  CAS  Google Scholar 

  47. Packard RC, O’Connell P. Medication compliance among headache patients. Headache 1986; 26: 416–9

    Article  Google Scholar 

  48. Mathew NT. Drug-induced headache. In: Mathew NR, editor. Neurology clinics. Vol. 8. Philadelphia: WB Saunders Co. 1990; 8: 903–12

    Google Scholar 

  49. de Lissovoy G, Lazarus SS. The economic cost of migraine. Neurology 1994; 44 Suppl. 4: S56–62

    PubMed  Google Scholar 

  50. Stewart WF, Lipton RB. The economic and social impact of migraine. Eur Neurol 1994; 34 Suppl. 2: 12–7

    Article  PubMed  Google Scholar 

  51. Stewart WF, Lipton RB. Societal impact of headache. In: Olesen J, Tfelt-Hansen P, Welch KMA, editors. The headaches. New York: Raven Press Ltd, 1993: 29–34

    Google Scholar 

  52. Feste C, Anderson RM. Empowerment: from philosophy to practice. Patient Educ Couns 1995; 26: 139–44

    Article  PubMed  CAS  Google Scholar 

  53. Lipton RB, Stewart WF, Von Korff M. Migraine impact and functional disability. Cephalalgia 1995; Suppl. 15: 4–9

    Google Scholar 

  54. Lipton RB, Amatniek JC, Ferrari MD, et al. Migraine: identifying and removing barriers to care. Neurology 1994; Suppl. 4: S63–8

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. The Headache Center, Department of Neurology, Henry Ford Hospital and Health Sciences Center, Detroit, Michigan, USA

    Stephanie J. Gilkey &  Nabih M. Ramadan

Authors
  1. Stephanie J. Gilkey
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Nabih M. Ramadan
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Nabih M. Ramadan.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gilkey, S.J., Ramadan, N.M. Use of Over-the-Counter Drugs in Migraine. CNS Drugs 6, 83–89 (1996). https://doi.org/10.2165/00023210-199606020-00001

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00023210-199606020-00001

Keywords

Search

Navigation